California Resources Corporation reported a $315 million net loss in Q3 2026, largely due to a $540 million non-cash derivative loss, but posted $104 million in adjusted net income and generated $147 million in free cash flow. The company increased its quarterly dividend by 4% to $0.42 per share, reflecting confidence in sustainable shareholder returns. Strategic moves include selling its Uinta Basin assets, acquiring Crimson Midstream to boost energy infrastructure, and partnering with Bloom Energy on carbon capture and clean power projects in California. Looking ahead, CRC plans to optimize its California operations, maintain capital discipline, and continue returning value to shareholders in 2027.
California Resources Corporation's Q3 2026 financial results provide context for energy market watchers. For readers following the energy sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: Out of 79 priced energy-sector US stocks tradable on Pluang, 14 rose and 65 fell today. Notable movers include Liberty Energy Inc. Class A common stock (LBRT) at USD 14.71 with a 1-day change of -12.83% and 100% sell order activity, Venture Global Inc. Class A common stock (VG) at USD 12.94 with a 1-day change of -12.51%, and Patterson-UTI Energy Inc. Common Stock (PTEN) at USD 11.80 with a 1-day change of -11.41%.
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
